DEVICE: MiSeqDx Cystic Fibrosis Clinical Sequencing Assay (6 Run) (00816270020026)
Device Identifier (DI) Information
MiSeqDx Cystic Fibrosis Clinical Sequencing Assay (6 Run)
15036620
Not in Commercial Distribution
DX-102-1001
ILLUMINA, INC.
15036620
Not in Commercial Distribution
DX-102-1001
ILLUMINA, INC.
The Illumina MiSeqDx Cystic Fibrosis Clinical Sequencing Assay consists of library preparation and sample indexing reagents, sequencing reagents and consumables, MiSeqDx instrument and data analysis software.
MiSeqDx Cystic Fibrosis Clinical Sequencing Assay is an IVD kit consisting of the individual boxes listed below which are all labeled with the same Device Identifier:
15035429 MiSeqDx Cystic Fibrosis Clinical Sequencing Assay 1/5
15038248 MiSeqDx Cystic Fibrosis Clinical Sequencing Assay 1A
15038249 MiSeqDx Cystic Fibrosis Clinical Sequencing Assay 1B
15035436 MiSeqDx Cystic Fibrosis Clinical Sequencing Assay 2/5
15035430 MiSeqDx Cystic Fibrosis Clinical Sequencing Assay 3/5
15038250 MiSeqDx Cystic Fibrosis Clinical Sequencing Assay 3A
15038251 MiSeqDx Cystic Fibrosis Clinical Sequencing Assay 3B
15036622 MiSeqDx Cystic Fibrosis Clinical Sequencing Assay 4/5
15036623 MiSeqDx Cystic Fibrosis Clinical Sequencing Assay 5/5
Device Characteristics
| Labeling does not contain MRI Safety Information | |
| No | |
| No | |
| Yes | |
| Yes | |
| No | |
| Yes | |
| No | |
| No |
GMDN
[?]GMDN© Term Code, Names and Definitions (*Terms of Use): GMDN® is a registered trademark of The GMDN Agency. All rights reserved. Used under licence from The GMDN Agency Ltd.
| GMDN Term Code | GMDN Term Name | GMDN Term Definition | GMDN Term Status [?] | Implantable? |
|---|---|---|---|---|
| 59365 | Cystic fibrosis IVD, kit, multiplex |
A collection of reagents and other associated materials intended to be used to evaluate a clinical specimen to diagnose, monitor or predict one or multiple mutations associated with the inborn genetic disorder cystic fibrosis due to mutation in the cystic fibrosis conductance regulator (CFTR) gene, using a multiplex method.
|
Obsolete | false |
FDA Product Code
[?]| Product Code | Product Code Name |
|---|---|
| PFS | System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Variant Gene Sequence Detection |
FDA Premarket Submission
| FDA Premarket Submission Number [?] | Supplement Number [?] |
|---|---|
| K132750 | 000 |
Sterilization
Storage and Handling
[?]| Storage and Handling |
|---|
| Storage Environment Temperature: between 15 and 30 Degrees Celsius |
| Storage Environment Temperature: between 15 and 25 Degrees Celsius |
| Storage Environment Temperature: between 2 and 8 Degrees Celsius |
Clinically Relevant Size
[?]| Size Type Text |
|---|
| No Device Sizes |
Device Record Status
0e2913bc-ca16-413e-aefa-e6d935e4dd34
January 31, 2023
4
September 21, 2016
January 31, 2023
4
September 21, 2016
Alternative and Additional Identifiers Additional Identifiers
Package DI
[?]| Package DI Number | Quantity per Package | Contains DI Package | Package Discontinue Date | Package Status | Package Type |
|---|---|---|---|---|---|
| No Package DIs found | |||||
Secondary DI
[?]| Issuing Agency [?] | Secondary DI Number |
|---|---|
| No Secondary DIs found | |
Unit of Use DI
[?]
Unit of Use DI Number:
No Unit of Use DI Numbers Found
CLOSE
Direct Marking (DM)
[?]Production Identifier(s) in UDI
[?]Customer Contact
[?]
No Customer Contact currently defined